Evidence map›Paper›PMID 21745411›Full record

ArticleLipids in health and disease2011

Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats.

Hyang Mi An, Shin Young Park, Do Kyung Lee, Jung Rae Kim, Min Kyeong Cha, Si Won Lee, Hyung Taeck Lim, Kyung Jae Kim, Nam Joo Ha

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 126 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed, 3 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 3 syntheses or guidelines pooled it, 313 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Effects ofNutrients · 2022
    Trial
  6. Trial
  7. Trial
  8. Gut microbial alterations and functional shifts in patients with hypertriglyceridemia: insights from a northwestern Chinese metagenomic study.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Importance of human microbiome: an update.Frontiers in microbiomes · 2026
    Review
  15. Structural Characterization of Polysaccharide fromFoods (Basel, Switzerland) · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hyang Mi AnCollege of Pharmacy, Sahmyook University, Seoul, Republic of Korea.
Shin Young Park
Do Kyung Lee
Jung Rae Kim
Min Kyeong Cha
Si Won Lee
Hyung Taeck Lim
Kyung Jae Kim
Nam Joo Ha
Sahmyook University · KRKorea Institute of Oriental Medicine · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent studies have reported the preventive effects of probiotics on obesity. Among commensal bacteria, bifidobacteria is one of the most numerous probiotics in the mammalian gut and are a type of lactic acid bacteria. The aim of this study was to assess the antiobesity and lipid-lowering effects of Bifidobacterium spp. isolated from healthy Korean on high fat diet-induced obese rats.

methodsThirty-six male Sprague-Dawley rats were divided into three groups as follows: (1) SD group, fed standard diet; (2) HFD group, fed high fat diet; and (3) HFD-LAB group, fed high fat diet supplemented with LAB supplement (B. pseudocatenulatum SPM 1204, B. longum SPM 1205, and B. longum SPM 1207; 108 ~ 109 CFU). After 7 weeks, the body, organ, and fat weights, food intake, blood serum levels, fecal LAB counts, and harmful enzyme activities were measured.

resultsAdministration of LAB reduced body and fat weights, blood serum levels (TC, HDL-C, LDL-C, triglyceride, glucose, leptin, AST, ALT, and lipase levels), and harmful enzyme activities (β-glucosidase, β-glucuronidase, and tryptophanase), and significantly increased fecal LAB counts.

conclusionThese data suggest that Bifidobacterium spp. used in this study may have beneficial antiobesity effects.

Indexed as

BifidobacteriumAlanine Transaminasealpha-AmylasesAnimalsAnti-Obesity AgentsAspartate Aminotransferasesbeta-GlucosidaseBlood GlucoseDietary FatsFecesGlucuronidaseHypolipidemic AgentsLeptinLipaseLipidsMaleAlanine Transaminasealpha-AmylasesAnti-Obesity AgentsAspartate Aminotransferasesbeta-GlucosidaseBlood GlucoseDietary FatsGlucuronidaseHypolipidemic AgentsLeptinLipaseLipidsTryptophanaseUrease

Identifiers

PMID21745411
PMCPMC3146849
OpenAlexW2170559209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.